Legal & General Group
IMA

Legal & General Group’s ImageneBio Inc IMA Stock Holding History

Legal & General Group’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-170
Closed -$2.9K – 3463
2024
Q1 		$2.9K Hold
170
– – ﹤0.01% 3332
2023
Q4 		$4.03K Hold
170
– – ﹤0.01% 3341
2023
Q3 		$8.86K Hold
170
– – ﹤0.01% 3292
2023
Q2 		$13.4K Buy
+170
New +$12.2K ﹤0.01% 3263
2022
Q2 		– Sell
-189
Closed -$14K – 3588
2022
Q1 		$14K Hold
189
– – ﹤0.01% 3320
2021
Q4 		$29K Buy
189
+111
+142% +$18K ﹤0.01% 3160
2021
Q3 		$12K Buy
78
+18
+30% +$2.62K ﹤0.01% 3413
2021
Q2 		$10K Buy
+60
New +$13.2K ﹤0.01% 3419

Other funds holding IMA

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Legal & General Group's IMA Position: Q2 2024 in Review

Legal & General Group sold out of ImageneBio Inc (IMA) in Q2 2024, closing a stake of 170 shares — an estimated $2.9K sold.

Legal & General Group first reported a position in IMA in Q2 2021 and held it in 8 quarters. The position peaked at $29K in Q4 2021. 70 funds tracked by Wall St. Rank hold IMA as of Q2 2024.

  • Legal & General Group reported no remaining ImageneBio Inc position as of Q2 2024 after selling out during the quarter.
  • Legal & General Group sold 170 ImageneBio Inc shares in Q2 2024, an estimated $2.9K.
  • Legal & General Group first reported a position in ImageneBio Inc in Q2 2021 and held it in 8 quarters.
  • Legal & General Group's ImageneBio Inc position peaked at $29K in Q4 2021.
  • 70 funds tracked by Wall St. Rank held ImageneBio Inc as of Q2 2024.

Based on Legal & General Group's 13F filing for Q2 2024, filed 14 Aug 2024.